- Featured Product
- KD/KO Validated
SMAD2 Polyclonal antibody
SMAD2 Polyclonal Antibody for IF, IHC, IP, WB,ELISA
Cat no : 12570-1-AP
|Positive WB detected in||HepG2 cells, multi-cells, Jurkat cells, HeLa cells, mouse skeletal muscle tissue, rat skeletal muscle tissue|
|Positive IP detected in||HepG2 cells|
|Positive IHC detected in||human endometrial cancer tissue, human heart tissue, human cervical cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||HepG2 cells|
|Western Blot (WB)||WB : 1:1000-1:6000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:2000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:10-1:100|
|Sample-dependent, check data in validation data gallery|
12570-1-AP targets SMAD2 in WB, IP, IHC, IF, CoIP, ChIP, ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||Cistanche Tubulosa, human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||SMAD2 fusion protein Ag3237|
|Full Name||SMAD family member 2|
|Calculated molecular weight||467 aa, 52 kDa|
|Observed molecular weight||58 kDa|
|GenBank accession number||BC014840|
|Gene ID (NCBI)||4087|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
SMAD2, also named as MADH2 and MADR2, belongs to the dwarfin/SMAD family, contains 1 MH1 (MAD homology 1) domain and 1 MH2 (MAD homology 2) domain. SMAD2 is a receptor-regulated SMAD(R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. This protein may act as a tumor suppressor in colorectal carcinoma. It is phosphorylated on one or several of Thr-220, Ser-245, Ser-250, and Ser-255. In response to TGF-beta, It is phosphorylated on Ser-465/467 by TGF-beta and activin type 1 receptor kinases, and then able to interact with SMURF2, recruiting other proteins, such as SNON, for degradation. In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, it is phosphorylated on Ser-240 by CaMK2. It is phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin. In response to TGF-beta, it is ubiquitinated by NEDD4L, which promotes its degradation. In response to TGF-beta signaling, it is acetylated on Lys-19 by coactivators, which increases transcriptional activity. This antibody is a rabbit polyclonal antibody raised against residues near the N terminus of human SMAD2. The molecular weight of unphosphorylated forms of Smad2 is 52 kDa and phosphorylated forms of Smad2 is 58 kDa. (PMID: 9006934)
|Product Specific Protocols|
|WB protocol for SMAD2 antibody 12570-1-AP||Download protocol|
|IHC protocol for SMAD2 antibody 12570-1-AP||Download protocol|
|IF protocol for SMAD2 antibody 12570-1-AP||Download protocol|
|IP protocol for SMAD2 antibody 12570-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Aging (Albany NY)
A CREB1/miR-433 reciprocal feedback loop modulates proliferation and metastasis in colorectal cancer.
POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.
Raw and vinegar processed Curcuma wenyujin regulates hepatic fibrosis via bloking TGF-β/Smad signaling pathways and up-regulation of MMP-2/TIMP-1 ratio.
A feedback loop between hypoxia and matrix stress relaxation increases oxygen-axis migration and metastasis in sarcoma.
Mol Med Rep
Astaxanthin ameliorates renal interstitial fibrosis and peritubular capillary rarefaction in unilateral ureteral obstruction.
Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.